| Committees | Independence | |||
|---|---|---|---|---|
| S. Louise Phanstiel |Chair | Audit and Finance, Nominating and Governance | Independent | 16 yr | Not disclosed |
| Heiner Dreismann, Ph.D.Director | Compensation and Human Capital (Chair), Research and Product Innovation | Independent | 15 yr | Not disclosed |
| Colleen F. ReitanDirector | Audit and Finance, Nominating and Governance (Chair) | Independent | 6 yr | Not disclosed |
| Lee N. Newcomer, M.D.Director | Compensation and Human Capital, Research and Product Innovation (Chair) | Independent | 6 yr | Not disclosed |
| Daniel M. Skovronsky, M.D., Ph.D.Director | Compensation and Human Capital, Research and Product Innovation | Independent | 5 yr | Not disclosed |
| Rashmi KumarDirector | Audit and Finance, Nominating and Governance | Independent | 5 yr | Not disclosed |
| Paul M. BisaroDirector | Compensation and Human Capital, Research and Product Innovation | Independent | 3 yr | Not disclosed |
| Mark S. DavisDirector | Audit and Finance (Chair), Nominating and Governance | Independent | 1 yr | Not disclosed |
8 seats
The board of the latest proxy statement.